Novel Chemical Mediators in the Resolution of Inflammation: Resolvins and Protectins

Anesthesiology Clinics of North America

Volumn 24, Issue 2, 2006, Pages 341-364

  Serhan, Charles N ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONIC ACID; CD59 ANTIGEN; DOCOSAHEXAENOIC ACID; GLUCOCORTICOID; ICOSANOID; ICOSAPENTAENOIC ACID; INDOMETACIN; LIPOXIN; NEUROPROTECTIN; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; RESOLVIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; BIOSYNTHESIS; BLOOD FLOW; CANCER; CARDIOVASCULAR DISEASE; CELL INTERACTION; EDEMA; EXUDATE; HEAT SENSATION; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE; LIQUID CHROMATOGRAPHY; MICROORGANISM; NERVOUS TISSUE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIODONTAL DISEASE; REVIEW; SKIN REDNESS; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIGENS, CD59; ARACHIDONIC ACID; ASPIRIN; COMPLEMENT INACTIVATING AGENTS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FATTY ACIDS, UNSATURATED; HUMANS; INFLAMMATION; NEUROPROTECTIVE AGENTS;

EID: 33646404335     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2006.01.003     Document Type: Review

References (106)

1. Burr G.O., and Burr M.M. A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 82 (1929) 345-367
2. In: Lands W.E.M. (Ed). Proceedings of the American Oil Chemists' Society Short Course on Polyunsaturated Fatty Acids and Eicosanoids (1987), American Oil Chemists' Society, Champaign (IL)
3. Bazan N.G. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In: Wurtman R.J., and Wurtman J.J. (Eds). Nutrition and the brain volume 8 (1990), Raven Press, New York 1-22
4. Simopoulos A.P., Leaf A., and Salem Jr. N. Workshop on the essentiality of and recommended dietary intakes for omega-6 and omega-3 fatty acids. J Am Coll Nutr 18 (1999) 487-489
5. Salem Jr. N., Litman B., Kim H.-Y., et al. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36 (2001) 945-959
6. Helgadottir A., Manolescu A., Thorleifsson G., et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36 (2004) 233-239
7. Erlinger T.P., Platz E.A., Rifai N., et al. C-reactive protein and the risk of incident colorectal cancer. JAMA 291 (2004) 585-590
8. Pasche B., and Serhan C.N. Is C-reactive protein an inflammation opsonin that signals colon cancer risk?. JAMA 291 (2004) 623-624
9. In: Gallin J.I., Snyderman R., Fearon D.T., et al. (Eds). Inflammation: basic principles and clinical correlates. 3rd edition (1999), Lippincott Williams & Wilkins, Philadelphia 1360
10. Van Dyke T.E., and Serhan C.N. Resolution of inflammation: a new paradigm for the pathogenesis of periodontal diseases. J Dent Res 82 (2003) 82-90
11. Serhan C.N., Clish C.B., Brannon J., et al. Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J Exp Med 192 (2000) 1197-1204
12. Serhan C.N., Hong S., Gronert K., et al. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter pro-inflammation signals. J Exp Med 196 (2002) 1025-1037
13. Hong S., Gronert K., Devchand P., et al. Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood and glial cells: autacoids in anti-inflammation. J Biol Chem 278 (2003) 14677-14687
14. Marcheselli V.L., Hong S., Lukiw W.J., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 278 (2003) 43807-43817
15. Mukherjee P.K., Marcheselli V.L., Serhan C.N., et al. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 101 (2004) 8491-8496
16. Majno G. The healing hand: man and wound in the ancient world (1975), Harvard University Press, Cambridge (MA)
17. Libby P. Atherosclerosis: the new view. Sci Am 286 (2002) 46-55
18. Drazen J.M., Israel E., and O'Byrne P.M. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 340 (1999) 197-206
19. Weiner H.L., and Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature 420 (2002) 879-884
20. Dale H.H. Pharmacology during the past sixty years. In: Gibson W.C. (Ed). The excitement and fascination of science: reflections by eminent scientists vol. 1 (1978), Annual Reviews, Palo Alto (CA) 75
21. von Euler U.S. Pieces in the puzzle. In: Gibson W.C. (Ed). The excitement and fascination of science: reflections by eminent scientists vol. 2 (1978), Annual Reviews, Palo Alto (CA) 675-686
22. Samuelsson B. From studies of biochemical mechanisms to novel biological mediators: prostaglandin endoperoxides, thromboxanes and leukotrienes. In: The Nobel Foundation, editors. Les prix Nobel: Nobel prizes, presentations, biographies and lectures. Stockholm, Sweden: Almqvist & Wiksell; 1982. p. 153-74
23. Tauber A.I., and Chernyak L. Metchnikoff and the origins of immunology: from metaphor to theory (1991), Oxford University Press, New York
24. Serhan C.N. A search for endogenous mechanisms of anti-inflammation uncovers novel chemical mediators: missing links to resolution. Histochem Cell Biol 122 (2004) 305-321
25. Borgeat P., and Samuelsson B. Arachidonic acid metabolism in polymorphonuclear leukocytes: effects of ionophore A23187. Proc Natl Acad Sci U S A 76 (1979) 2148-2152
26. In: Cassatella M.A. (Ed). Chemical Immunology and Allergy. The Neutrophil, vol 83 (2003), Karger, Basel, Switzerland
27. Gilroy D.W., and Perretti M. Aspirin and steroids: new mechanistic findings and avenues for drug discovery. Curr Opin Pharmacol 5 (2005) 405-411
28. Serhan C.N. Lipoxin biosynthesis and its impact in inflammatory and vascular events. Biochim Biophys Acta 1212 (1994) 1-25
29. Lawrence T., Willoughby D.A., and Gilroy D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat Rev Immunol 2 (2002) 787-795
30. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
31. Lu Y., Hong S., Tjonahen E., et al. Mediator-lipidomics: databases and search algorithms for PUFA-derived mediators. J Lipid Res 46 (2005) 790-802
32. Levy B.D., Clish C.B., Schmidt B., et al. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2 (2001) 612-619
33. In: Cotran R.S., Kumar V., and Collins T. (Eds). Robbins pathologic basis of disease. 6th edition (1999), WB Saunders, Philadelphia 1425
34. Williams T.J., and Peck M.J. Role of prostaglandin-mediated vasodilatation in inflammation. Nature 270 (1977) 530-532
35. Pouliot M., Fiset M.E., Masse M., et al. Adenosine up-regulates cyclooxygenase-2 in human granulocytes: impact on the balance of eicosanoid generation. J Immunol 169 (2002) 5279-5286
36. Gilroy D.W., Colville-Nash P.R., Willis D., et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 5 (1999) 698-701
37. 4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 34 (1995) 14609-14615
38. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion. J Clin Invest 104 (1999) 309-316
39. 4 stable analogues. J Clin Invest 101 (1998) 819-826
40. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183 (1996) 137-146
41. Godson C., Mitchell S., Harvey K., et al. Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164 (2000) 1663-1667
42. 4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 92 (1993) 75-82
43. Lawrence T., Bebien M., Liu G.Y., et al. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434 (2005) 1138-1143
44. Bannenberg G.L., Chiang N., Ariel A., et al. Molecular circuits of resolution: Formation and actions of resolvins and protectins. J Immunol 174 (2005) 4345-4355
45. Perretti M., and Getting S.J. Migration of specific leukocyte subsets in response to cytokine or chemokine application in vivo. In: Winyard P.G., and Willoughby D.A. (Eds). Inflammation protocols vol. 225 (2003), Humana Press, Totowa (NJ) 139-146
46. Arita M., Bianchini F., Aliberti J., et al. Stereochemical assignment, anti-inflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 201 (2005) 713-722
47. GISSI-Prevenzione Investigators (Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico). Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 9177 (1999) 447-455
48. Marchioli R., Barzi F., Bomba E., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002) 1897-1903
49. Arita M., Yoshida M., Hong S., et al. Resolvin E1, a novel endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against TNBS-induced colitis. Proc Natl Acad Sci U S A 102 (2005) 7671-7676
50. Wallace J.L., and Fiorucci S. A magic bullet for mucosal protection: and aspirin is the trigger!. Trends Pharmacol Sci 24 (2003) 323-326
51. Fukunaga K., Kohli P., Bonnans C., et al. Cyclooxygenase 2 plays a pivotal role in the resolution of acute lung injury. J Immunol 174 (2005) 5033-5039
52. Gilroy D.W., Lawrence T., Perretti M., et al. Inflammation resolution: new opportunities for drug discovery. Nat Rev Drug Discov 3 (2004) 401-416
53. Vane J.R. Adventures and excursions in bioassay: the stepping stones to prostacyclin. Les prix Nobel: Nobel prizes, presentations, biographies and lectures (1982), Almqvist & Wiksell, Stockholm, Sweden 181-206
54. Clària J., and Serhan C.N. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci U S A 92 (1995) 9475-9479
55. Mitchell S., Thomas G., Harvey K., et al. Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13 (2002) 2497-2507
56. Lehr H.-A., Olofsson A.M., Carew T.E., et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 71 (1994) 380-386
57. Mora J.R., Bono M.R., Manjunath N., et al. Selective imprinting of gut-homing T cells by Peyer's patch dendritic cells. Nature 424 (2003) 88-93
58. Serhan C.N., Hamberg M., and Samuelsson B. Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes. Proc Natl Acad Sci U S A 81 (1984) 5335-5339
59. 4 by platelet 12-lipoxygenase in vitro. J Clin Invest 85 (1990) 772-780
60. Marcus A.J. Platelets: their role in hemostasis, thrombosis, and inflammation. In: Gallin J.I., and Snyderman R. (Eds). Inflammation: basic principles and clinical correlates (1999), Lippincott Williams & Wilkins, Philadelphia 77-95
61. 4 with human neutrophils. J Biol Chem 267 (1992) 16168-16176
62. 4 receptor. J Exp Med 180 (1994) 253-260
63. 4 in human neutrophils. Mol Pharmacol 63 (2003) 721-730
64. 4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 168 (2002) 5260-5267
65. Perretti M., Chiang N., La M., et al. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat Med 8 (2002) 1296-1302
66. Vane J.R. Back to an aspirin a day?. Science 296 (2002) 474-475
67. 2. Science 296 (2002) 539-541
68. 4 inhibit human neutrophil migration: comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells. J Immunol 170 (2003) 2688-2694
69. 4. J Pharmacol Exp Ther 300 (2002) 385-392
70. Kieran N.E., Doran P.P., Connolly S.B., et al. Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int 64 (2003) 480-492
71. Devchand P.R., Arita M., Hong S., et al. Human ALX receptor regulates neutrophil recruitment in transgenic mice: Roles in inflammation and host-defense. FASEB J 17 (2003) 652-659
72. Serhan C.N., Jain A., Marleau S., et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 171 (2003) 6856-6865
73. Weissmann G., Smolen J.E., and Korchak H.M. Release of inflammatory mediators from stimulated neutrophils. N Engl J Med 303 (1980) 27-34
74. Rosenstein E.D., Kushner L.J., Kramer N., et al. Pilot study of dietary fatty acid supplementation in the treatment of adult periodontitis. Prostaglandins Leukot Essent Fatty Acids 68 (2003) 213-218
75. Bazan N.G. Supply, uptake, and utilization of docosahexaenoic acid during photoreceptor cell differentiation. Nestle Nutrition Workshop Series 28 (1992) 121-133
76. Lee T.H., Mencia-Huerta J.-M., Shih C., et al. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 74 (1984) 1922-1933
77. Sawazaki S., Salem Jr. N., and Kim H.-Y. Lipoxygenation of docosahexaenoic acid by the rat pineal body. J Neurochem 62 (1994) 2437-2447
78. 4-neuroprostanes) in vivo from docosahexaenoic acid. Biochemistry 39 (2000) 2376-2383
79. VanRollins M., Baker R.C., Sprecher H.W., et al. Oxidation of docosahexaenoic acid by rat liver microsomes. J Biol Chem 259 (1984) 5776-5783
80. Lands W.E.M. Diets could prevent many diseases. Lipids 38 (2003) 317-321
81. In: Winyard P.G., and Willoughby D.A. (Eds). Methods in Molecular Biology. Inflammation Protocols, vol 225 (2003), Humana Press, Totowa (NJ) 378
82. Serhan C.N., Gotlinger K., Hong S., et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J Immunol 176 (2006) 1848-1859
83. Capdevila J.H., Wei S., Helvig C., et al. The highly stereoselective oxidation of polyunsaturated fatty acids by cytochrome P450BM-3. J Biol Chem 271 (1996) 22663-22671
84. Arita M., Clish C.B., and Serhan C.N. The contributions of aspirin and microbial oxygenase in the biosynthesis of anti-inflammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun 338 (2005) 149-157
85. Corey E.J., Shih C., and Cashman J.R. Docosahexaenoic acid is a strong inhibitor of prostaglandin but not leukotriene biosynthesis. Proc Natl Acad Sci U S A 80 (1983) 3581-3584
86. Serhan C.N., and Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 107 (2001) 1481-1489
87. Gronert K., Maheshwari N., Khan N., et al. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J Biol Chem 280 (2005) 15267-15278
88. Hasturk H., Kantarci A., Ohira T., et al. RvE1 protects from local inflammation and osteoclast mediated bone destruction in periodontitis. FASEB J 20 (2006) 401-403
89. Duffield J.S., Hong S., Vaidya V., et al. Omega-3 lipid mediators resolvin D and protectin D limit injury and acute renal failure following ischemia/reperfusion [abstract]. J Am Soc Nephrol 16 (2005) 17A
90. H2 skewing and promotes human T cell apoptosis via lipid raft clustering. J Biol Chem 280 (2005) 43079-43086
91. Lukiw W.J., Cui J.G., Marcheselli V.L., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 115 (2005) 2774-2783
92. Coffa G., and Brash A.R. A single active site residue directs oxygenation stereospecificity in lipoxygenases: stereocontrol is linked to the position of oxygenation. Proc Natl Acad Sci U S A 101 (2004) 15579-15584
93. Hessler T.G., Thomson M.J., Benscher D., et al. Association of a lipoxygenase locus, Lpx-B1, with variation in lipoxygenase activity in durum wheat seeds. Crop Science 42 (2002) 1695-1700
94. Rådmark O. Arachidonate 5-lipoxygenase. Prostaglandins Other Lipid Mediat 68-69 (2002) 211-234
95. Funk C.D., Chen X.S., Johnson E.N., et al. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat 68-69 (2002) 303-312
96. Kuhn H., and Thiele B.J. The diversity of the lipoxygenase family: many sequence data but little information on biological significance. FEBS Lett 449 (1999) 7-11
97. Furstenberger G., Marks F., and Krieg P. Arachidonate 8(S)-lipoxygenase. Prostaglandins Other Lipid Mediat 68-69 (2002) 235-243
98. Vance R.E., Hong S., Gronert K., Serhan C.N., et al. The opportunistic pathogen Pseudomonas aeruginosa carries a novel secretable arachidonate 15-lipoxygenase. Proc Natl Acad Sci U S A 101 (2004) 2135-2139
99. Hong S., Tjonahen E., Morgan E.L., et al. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins-mediator lipidomic analysis. Prostaglandins Other Lipid Mediat 78 (2005) 107-116
100. Rowley A.F., Lloyd-Evans P., Barrow S.E., et al. Lipoxin biosynthesis by trout macrophages involves the formation of epoxide intermediates. Biochemistry 33 (1994) 856-863
101. Majno G., and Joris I. Cells, tissues, and disease: principles of general pathology. 2nd edition (2004), Oxford University Press, New York
102. Samuelsson B., Dahlén S.E., Lindgren J.Å., et al. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237 (1987) 1171-1176
103. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294 (2001) 1871-1875
104. Capdevila J.H., Falck J.R., Dishman E., et al. Cytochrome P-450 arachidonate oxygenase. In: Murphy R.C., and Fitzpatrick F.A. (Eds). Arachidonate related lipid mediators vol. 187 (1990), Academic Press, San Diego (CA) 385-394
105. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 285 (1999) 1276-1279
106. Rodriguez A.R., and Spur B.W. First total synthesis of 7(S),16(R),17(S)-Resolvin D2, a potent anti-inflammatory lipid mediator. Tetrahedron Lett 45 (2004) 8717-8720